SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001262463-14-000362
Filing Date
2014-04-29
Accepted
2014-04-29 12:00:04
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plpl10k2013.htm 10-K/A 491010
2 EXHIBIT 31.1 ex311.htm EX-31 7857
3 EXHIBIT 31.2 ex312.htm EX-31 7830
4 EXHIBIT 32.1 ex321.htm EX-32 4194
5 EXHIBIT 32.2 ex322.htm EX-32 4255
  Complete submission text file 0001262463-14-000362.txt   2885609

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE fil-20130630.xml EX-101.INS 245732
7 XBRL SCHEMA FILE fil-20130630.xsd EX-101.SCH 29621
8 XBRL CALCULATION FILE fil-20130630_cal.xml EX-101.CAL 51285
9 XBRL DEFINITION FILE fil-20130630_def.xml EX-101.DEF 115000
10 XBRL LABEL FILE fil-20130630_lab.xml EX-101.LAB 214351
11 XBRL PRESENTATION FILE fil-20130630_pre.xml EX-101.PRE 185669
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (435) 881-8734
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-51206 | Film No.: 14792357
SIC: 2834 Pharmaceutical Preparations